Method for Determining Drug-Sensitive Human Cell Lines by Analysis Method in Which Measurement of Activity of Two Types of Protein Kinase Is Used
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/JP2016/080544, filed Oct 14, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,724,071 | Method for Determining Drug-Sensitive Human Cell Lines by Analysis Method in Which Measurement of Activity of Two Types of Protein Kinase Is Used In force · High confidence | Nitto Boseki Co., Ltd. | In force | High confidence | ||
| US 10,995,359 | Method for Determining Drug-Sensitive Human Cell Lines by Analysis Method in Which Measurement of Activity of Two Types of Protein Kinase Is Used In force · High confidence | Nitto Boseki Co., Ltd. | In force | High confidence | ||
| US 11,372,001 | Anti-Human IGG4 Monoclonal Antibody and Methods of Making and Using Same In force · High confidence | Nitto Boseki Co., Ltd. | In force | High confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.